Human Molecular Genetics Advance Access originally published online on November 24, 2004
Human Molecular Genetics 2005 14(2):279-293; doi:10.1093/hmg/ddi025
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 14, No. 2 © Oxford University Press 2005; all rights reserved
Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy
1Cell and Matrix Biology, Murdoch Childrens Research Institute and Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria 3052, Australia, 2Department of Cell and Molecular Biology, Section of Molecular Pathogenesis, Lund University, 221 84 Lund, Sweden, 3Institute for Neuromuscular Research, The Children's Hospital at Westmead and Department of Paediatrics and Child Health, University of Sydney, Australia and 4Department of Paediatric Neurology, University Hospital, Leuven, Belgium
* To whom correspondence should be addressed. Tel: +61 393456650; Fax: +61 393457997; Email: shireen.lamande{at}mcri.edu.au
Received June 1, 2004; Accepted November 11, 2004
Mutations in the three collagen VI genes COL6A1, COL6A2 and COL6A3 cause Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD). UCMD, a severe disorder characterized by congenital muscle weakness, proximal joint contractures and marked distal joint hyperextensibility, has been considered a recessive condition, and homozygous or compound heterozygous mutations have been defined in COL6A2 and COL6A3. In contrast, the milder disorder Bethlem myopathy shows clear dominant inheritance and is caused by heterozygous mutations in COL6A1, COL6A2 and COL6A3. This model, where dominant mutations cause mild Bethlem myopathy and recessive mutations cause severe UCMD was recently challenged when a patient with UCMD was shown to have a heterozygous in-frame deletion in COL6A1. We have studied five patients with a clinical diagnosis of UCMD. Three patients had heterozygous in-frame deletions in the N-terminal region of the triple helical domain, one in the
1(VI) chain, one in
2(VI) and one in
3(VI). Collagen VI protein biosynthesis and assembly studies showed that these mutations act in a dominant negative fashion and result in severe collagen VI matrix deficiencies. One patient had recessive amino acid changes in the C2 subdomain of
2(VI), which prevented collagen VI assembly. No collagen VI mutations were found in the fifth patient. These data demonstrate that rather than being a rare cause of UCMD, dominant mutations are common in UCMD, now accounting for four of the 14 published cases. Mutation detection in this disorder remains critical for accurate genetic counseling of patients and their families.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Merlini, E. Martoni, P. Grumati, P. Sabatelli, S. Squarzoni, A. Urciuolo, A. Ferlini, F. Gualandi, and P. Bonaldo Autosomal recessive myosclerosis myopathy is a collagen VI disorder Neurology, October 14, 2008; 71(16): 1245 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Peat, J. M. Smith, A. G. Compton, N. L. Baker, R. A. Pace, D. J. Burkin, S. J. Kaufman, S. R. Lamande, and K. N. North Diagnosis and etiology of congenital muscular dystrophy Neurology, July 29, 2008; 71(5): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fitzgerald, C. Rich, F. H. Zhou, and U. Hansen Three Novel Collagen VI Chains, {alpha}4(VI), {alpha}5(VI), and {alpha}6(VI) J. Biol. Chem., July 18, 2008; 283(29): 20170 - 20180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gara, P. Grumati, A. Urciuolo, P. Bonaldo, B. Kobbe, M. Koch, M. Paulsson, and R. Wagener Three Novel Collagen VI Chains with High Homology to the {alpha}3 Chain J. Biol. Chem., April 18, 2008; 283(16): 10658 - 10670. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Merlini, A. Angelin, T. Tiepolo, P. Braghetta, P. Sabatelli, A. Zamparelli, A. Ferlini, N. M. Maraldi, P. Bonaldo, and P. Bernardi Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies PNAS, April 1, 2008; 105(13): 5225 - 5229. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hicks, A. K. Lampe, R. Barresi, R. Charlton, C. Fiorillo, C. G. Bonnemann, J. Hudson, R. Sutton, H. Lochmuller, V. Straub, et al. A refined diagnostic algorithm for Bethlem myopathy Neurology, April 1, 2008; 70(14): 1192 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sipila, H. Ruotsalainen, R. Sormunen, N. L. Baker, S. R. Lamande, M. Vapola, C. Wang, Y. Sado, A. Aszodi, and R. Myllyla Secretion and Assembly of Type IV and VI Collagens Depend on Glycosylation of Hydroxylysines J. Biol. Chem., November 16, 2007; 282(46): 33381 - 33388. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Spangenberg and G. L. Waring A Mutant dec-1 Transgene Induces Dominant Female Sterility in Drosophila melanogaster Genetics, November 1, 2007; 177(3): 1595 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, G. Kawahara, S. Noguchi, K. Sugie, K. Murayama, I. Nonaka, Y. K. Hayashi, and I. Nishino Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan Neurology, September 4, 2007; 69(10): 1035 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kawahara, M. Okada, N. Morone, C. A. Ibarra, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease Neurology, September 4, 2007; 69(10): 1043 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Kadler, C. Baldock, J. Bella, and R. P. Boot-Handford Collagens at a glance J. Cell Sci., June 15, 2007; 120(12): 1955 - 1958. [Full Text] [PDF] |
||||
![]() |
A. Angelin, T. Tiepolo, P. Sabatelli, P. Grumati, N. Bergamin, C. Golfieri, E. Mattioli, F. Gualandi, A. Ferlini, L. Merlini, et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins PNAS, January 16, 2007; 104(3): 991 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tetreault, A. Duquette, I. Thiffault, C. Bherer, J. Jarry, L. Loisel, B. Banwell, G. D'Anjou, J. Mathieu, Y. Robitaille, et al. A new form of congenital muscular dystrophy with joint hyperlaxity maps to 3p23-21 Brain, August 1, 2006; 129(8): 2077 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lamande, M. Morgelin, N. E. Adams, C. Selan, and J. M. Allen The C5 Domain of the Collagen VI {alpha}3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells J. Biol. Chem., June 16, 2006; 281(24): 16607 - 16614. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Malfait, A. J. Hakim, A. De Paepe, and R. Grahame The genetic basis of the joint hypermobility syndromes Rheumatology, May 1, 2006; 45(5): 502 - 507. [Full Text] [PDF] |
||||
![]() |
A K Lampe and K M D Bushby Collagen VI related muscle disorders J. Med. Genet., September 1, 2005; 42(9): 673 - 685. [Abstract] [Full Text] [PDF] |
||||







